December 28, 2022 10:37 PM EST
Financing
Startups
Coronavirus

Scoop: To fund Covid-19 nasal vac­cine boost­er, Yale spin­out snags Se­ries A

Kyle LaHucik

Senior Reporter

A biotech work­ing to cre­ate an in­tranasal vac­cine boost­er for the on­go­ing Covid-19 pan­dem­ic has raised a Se­ries A, the start­up’s CEO con­firmed to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times